News

Unite for Change Makes it Easy for Canadians to Take Action This Earth Day

Newly launched Unite for Change platform by CanadaHelps enables Canadians to drive meaningful change by supporting multiple charities through a…

2 years ago

CLS Americas and URN Announce First Patient Treated in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”

Minimally Invasive, Outpatient Treatment Designed for Office or ClinicIRVINE, Calif. and MIAMI, April 20, 2022 (GLOBE NEWSWIRE) -- CLS Americas,…

2 years ago

Indicative offer to acquire 100% of the share capital of RAMSAY HEALTH CARE LIMITED (RAMSAY GENERALE DE SANTE’S Australian reference shareholder)

PRESS RELEASEParis, April 20th 2022 INDICATIVE OFFER TO ACQUIRE 100% OF THE SHARE CAPITAL OF RAMSAY HEALTH CARE LIMITED (RAMSAY…

2 years ago

Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults

First subject vaccinated in Phase 3 clinical trial of MVA-BN® RSV against respiratory syncytial virus (RSV) in older adultsTrial will…

2 years ago

Liisa Hurme appointed President and CEO of Orion Corporation as of 1 November 2022

PHOTO: Liisa Hurme (Photographer: Orion/Miika Kainu) Liisa HurmeORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION20 APRIL 2022 at 8:30 a.m.…

2 years ago

PIVLAZ (clazosentan) – Idorsia’s first commercial product – now available for patients in Japan

In Japan, PIVLAZ™ (clazosentan) 150 mg, is indicated for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction and cerebral ischemic…

2 years ago

Sienna Senior Living Inc. Announces Results From Annual and Special Meeting

MARKHAM, Ontario, April 19, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) is pleased…

2 years ago

Adverum Biotechnologies Announces Upcoming Data Presentations at ARVO 2022

Szilárd Kiss, M.D. to present new post-hoc analyses from the Phase 1 OPTIC Trial of ADVM-022 (AAV.7m8-aflibercept) in wet AMDREDWOOD…

2 years ago

Ocugen, Inc. to Present at NobleCon18

MALVERN, Pa., April 19, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and…

2 years ago

Premier Health Announces Grant of Options and Deferred Share Units

Premier Health of America Inc.MONTRÉAL, April 19, 2022 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (“Premier Health”…

2 years ago